Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Hess

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Clinical & Developmental Immunology|June 14, 2012
Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetesGreg S Gojanovich, Paul R Hess
Veterinary and Comparative Oncology|November 6, 2025
Phase 1 Dose Escalation of Single-Agent Mechlorethamine in Dogs With LymphomaLaura E Chadsey, Paul R Hess, Joanne L Intile
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
Platelets: covert regulators of lymphatic developmentCara C Bertozzi, Paul R Hess, Mark L Kahn
HLA|February 2, 2021
Dog leukocyte antigen-88*034:01 presents nonamer peptides from canine distemper virus hemagglutinin, large polymerase, and matrix proteinsPaige S Nemec, Jennifer C Holmes, Paul R Hess
Circulation Research|March 29, 2014
Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrityYacine Boulaftali, Paul R Hess, Mark L Kahn, et al.
HLA|September 22, 2018
The prevalent Boxer MHC class Ia allotype dog leukocyte antigen (DLA)-88*034:01 preferentially binds nonamer peptides with a defined motifPaige S Nemec, Alexander Kapatos, Jennifer C Holmes, et al.
Veterinary Immunology and Immunopathology|October 16, 2012
A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88Peter Ross, Jennifer C Holmes, Gregory S Gojanovich, et al.
Veterinary Medicine (Auckland, N.Z.)|July 28, 2018
Canine scent detection of canine cancer: a feasibility studyDavid C Dorman, Melanie L Foster, Katherine E Fernhoff, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigenPaul R Hess, David Boczkowski, Smita K Nair, et al.
Immunogenetics|June 27, 2021
High-resolution characterization of the structural features and genetic variation of six feline leukocyte antigen class I loci via single molecule, real-time (SMRT) sequencingJennifer C Holmes, Elizabeth H Scholl, Allison N Dickey, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Clinical & Developmental Immunology|June 14, 2012
Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetesGreg S Gojanovich, Paul R Hess
Veterinary and Comparative Oncology|November 6, 2025
Phase 1 Dose Escalation of Single-Agent Mechlorethamine in Dogs With LymphomaLaura E Chadsey, Paul R Hess, Joanne L Intile
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 2010
Platelets: covert regulators of lymphatic developmentCara C Bertozzi, Paul R Hess, Mark L Kahn
HLA|February 2, 2021
Dog leukocyte antigen-88*034:01 presents nonamer peptides from canine distemper virus hemagglutinin, large polymerase, and matrix proteinsPaige S Nemec, Jennifer C Holmes, Paul R Hess
Circulation Research|March 29, 2014
Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrityYacine Boulaftali, Paul R Hess, Mark L Kahn, et al.
HLA|September 22, 2018
The prevalent Boxer MHC class Ia allotype dog leukocyte antigen (DLA)-88*034:01 preferentially binds nonamer peptides with a defined motifPaige S Nemec, Alexander Kapatos, Jennifer C Holmes, et al.
Veterinary Immunology and Immunopathology|October 16, 2012
A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88Peter Ross, Jennifer C Holmes, Gregory S Gojanovich, et al.
Veterinary Medicine (Auckland, N.Z.)|July 28, 2018
Canine scent detection of canine cancer: a feasibility studyDavid C Dorman, Melanie L Foster, Katherine E Fernhoff, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigenPaul R Hess, David Boczkowski, Smita K Nair, et al.
Immunogenetics|June 27, 2021
High-resolution characterization of the structural features and genetic variation of six feline leukocyte antigen class I loci via single molecule, real-time (SMRT) sequencingJennifer C Holmes, Elizabeth H Scholl, Allison N Dickey, et al.
Pageof 5